Surgeons described it as the most exciting era in the history of eye care, with more ophthalmology breakthroughs still to ...

More than 5,000 ear, nose and throat specialists will gather in Los Angeles to share new research and advances in hearing, ...

Gene therapy partly restored sight in some blind people, with limited side effects reported in a 10-patient trial of an ...

Prioritize viral vectors, oncology and rare disease therapies, with North America offering strong ROI potential through regulatory support, R&D investment and early adoptionDublin, Oct. 08, 2026 ...

Record global approvals, CRISPR breakthroughs, and expanding clinical and commercial activity are accelerating demand for cell and gene therapy tools and reagents.Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE ...

Explore advancements in disease detection using artificial intelligence to diagnose rare genetic disorders in children faster ...

A new Pediatric Research commentary argues that insurance coverage and reimbursement policy, not the underlying science, now ...

The moment Kate Heath saw her 12-year-old pug, Ivy, sitting silently and staring at a wall, she knew something was wrong.

JEDDAH: Researchers and physicians will examine how cell and gene therapies can be translated into clinical treatments at the ...

A new class of medicines offers steadier protection with fewer injections, while gene therapy is beginning to test the promise of a one-time treatment.

Gene therapy has opened new possibilities for treating and potentially curing diseases by addressing their underlying genetic ...

Ocugen appoints Jolanda Crombach as General Manager of its European affiliate to advance gene therapy programs for blindness diseases.